Recent Updates
Recently added Catalysts
VNDA

Vanda Pharmaceuticals Announces Participation at the Citi 16th Annual BioPharma Virtual Conference

Key Takeaway: WASHINGTON, Sept. 7, 2021 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that Vanda's management will participate at the Citi 16th Annual BioPharma Virtual Conference taking place between September 8 and September 10, 2021. Vanda management will
Price reaction · baseline $16.74 (2021-09-03 close) · hit after-hours · clean, no other VNDA news in the window
day 0 close · peak
+0.5%

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+121%
120-day peak, hindsight
Typical move
19.9%
average across 7 past catalysts
Cash runway
~16 mo
Low dilution risk
Lead asset
Imsidolimab
Phase 2 · Palmoplantar Pustulosis

Full Press Release Details

WASHINGTON, Sept. 7, 2021 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that Vanda's management will participate at the Citi 16th Annual BioPharma Virtual Conference taking place between September 8 and September 10, 2021. Vanda management will host investor meetings. Vanda has updated its corporate presentation, which may be accessed on Vanda's website, www.vandapharma.com, by clicking on the Investors tab and following the Corporate Presentation link.
About Vanda Pharmaceuticals Inc.
Chief Corporate Affairs and Communications Officer
Vanda Pharmaceuticals Inc.
Head of Corporate Affairs
Vanda Pharmaceuticals Inc.
Last updated: Sep 7, 2021